<DOC>
	<DOCNO>NCT01251588</DOCNO>
	<brief_summary>The objective study examine 5-year efficacy safety Matrix-Induced Autologous Chondrocyte Implantation ( MACI® Implant ) , compare arthroscopic microfracture , patient receive study treatment Genzyme-sponsored study MACI00206 [ NCT00719576 ] treatment symptomatic articular cartilage defect femoral condyle , include trochlea .</brief_summary>
	<brief_title>Extension Study Participants Previous Study MACI00206 NCT00719576 MACI® Implant Treatment Symptomatic Articular Cartilage Defects Femoral Condyle</brief_title>
	<detailed_description />
	<mesh_term>Cartilage Diseases</mesh_term>
	<criteria>Patients receive study treatment ( MACI implant microfracture ) MACI00206 [ NCT00719576 ] study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Cartilage legion ,</keyword>
	<keyword>Symptomatic focal cartilage defect ,</keyword>
	<keyword>Microfracture ,</keyword>
	<keyword>MACI ,</keyword>
	<keyword>Autologous chondrocyte ,</keyword>
	<keyword>Trochlea</keyword>
</DOC>